Dawon Pharm

Dawon Pharm is a South Korean pharmaceutical company that specializes in the development and distribution of therapeutic products, with a significant focus on innovative oncology treatments. Through its affiliate Dawon Medax, the company is a pioneer in Accelerator-based Boron Neutron Capture Therapy (A-BNCT), a targeted radiotherapeutic modality designed to treat refractory cancers. This technology utilizes a linear accelerator and boron-10 compounds to selectively destroy cancer cells while sparing healthy tissue. Dawon Pharm maintains a robust portfolio of generic pharmaceuticals and medical supplies alongside its high-tech R&D efforts. The company leverages the engineering expertise of its parent group, Dawon Sys, to integrate advanced medical device technology with pharmaceutical development. Their clinical pipeline currently focuses on indications such as glioblastoma and recurrent head and neck cancer.